Astellas Pharma (ALPMY) Q2 2023 Earnings

27AprConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
-0.19
-0.03
0.13
0.3

Details

Expected EPS
-0.10448274315780035
Actual EPS
-0.19050537361175468
Surprise EPS
-0.09
Surprise Percent
+82.33%

Description

Astellas Pharma (ALPMY) has reported earnings of -0.19050537361175468 per share for Q2 2023.

0 Comments

Share your thoughts